Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Bharat Rangarajan"'
Autor:
Anant Ramaswamy, Vikas Ostwal, Nikhil Pande, Atul Sharma, Shekar Patil, Ravi Thippeswamy, Nikhil Ghadyalpatil, Rakesh Roy, Harish Peshwe, Bhavesh Poladia, Deepan Rajamanickam, Bharat Rangarajan, P R Neelesh Reddy, Vimal Pandita, Ashis Mukherjee, Aniket Thoke, Abhijit Sarkar, C T Satish, H Shashidara, S D Banavali
Publikováno v:
South Asian Journal of Cancer, Vol 8, Iss 1, Pp 22-26 (2019)
Background: Regorafenib is considered a standard of care as third-line therapy in metastatic colorectal cancers (mCRCs). Materials and Methods: The study was based on a computerized clinical data form sent to oncologists across the country for entry
Externí odkaz:
https://doaj.org/article/7e56f6cbb0db4d42bbd0cb160c123c88
Autor:
Vikas Ostwal, Atul Sharma, Ashis Mukherjee, Harish Peshwe, Nikhil Pande, Rakesh Roy, Ravi Thippeswamy, N. Ghadyalpatil, Anant Ramaswamy, P R Neelesh Reddy, Shekar Patil, Aniket Thoke, Abhijit Sarkar, Bharat Rangarajan, Bhavesh Poladia, HP Shashidara, Vimal Pandita, C T Satish, S D Banavali, Deepan Rajamanickam
Publikováno v:
South Asian Journal of Cancer, Vol 8, Iss 1, Pp 22-26 (2019)
South Asian Journal of Cancer
South Asian Journal of Cancer
Background: Regorafenib is considered a standard of care as third-line therapy in metastatic colorectal cancers (mCRCs). Materials and Methods: The study was based on a computerized clinical data form sent to oncologists across the country for entry
Autor:
Ajit Sugunan Shinto, Raghi Paramben Jose, Koramadai Karuppusamy Kamaleshwaran, Bharat Rangarajan
Publikováno v:
World Journal of Nuclear Medicine
World Journal of Nuclear Medicine, Vol 17, Iss 4, Pp 296-298 (2018)
World Journal of Nuclear Medicine, Vol 17, Iss 4, Pp 296-298 (2018)
Renal cell carcinoma (RCC) of the native kidney accounts for